Shown to be effective against bacteria most frequently associated with wound infections: Staphylococcuss aureus, Streptococcuss pyogenes, Pseudomonas aeruginosa (pyocyanic bacillus), MRSA, Enterococcus faecalis VRE, Escherichia coli and Candida albicans (1) Due to the non-adhesive nature of the dressing, Urgotul Absorb is recommended in the treatment of wounds in which the surrounding skin is weakened. If required UrgoTul Absorb and UrgoTul Absorb Heel can be cut using sterile equipment to adjust the size of the dressing to fit the wound. Accident & Emergency Equipment Audiometry Autoclaves and Accessories Blood Collection Blood Pressure Monitors & ABPM Defibrillators Dermatology Diagnostics Dopplers Dressings & Wound Care Greasy, neutral or impregnated dressings, e.g. tulle gras have been used for many years to treat acute skin lesions (injuries, burns, etc.). The aim is to create and maintain a local environment conducive to the healing process based on the concept of healing in a moist environment (3). However, in actual practice, these greasy dressings often dry out and require frequent dressing changes, and they almost always adhere to wounds causing wounds to bleed upon their removal. This makes wound care painful and disruptive to the healing process. An improved form of dressing was required, one which could provide an ideal moist healing environment and at the same time overcome many of the traditional problems of adherence, trauma and pain associated with conventional adherent dressings.

UrgoTul Ag | Urgo Medical

UrgoTul Absorb and UrgoTul Absorb Heel dressings should be changed every 2 to 4 days, depending on the exudate volume and the clinical condition of the wound. UrgoTul Absorb is indicated for all exuding chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers), acute wounds (2nd degree burns, skin abrasions, traumatic wounds, post-operative wounds….) and for the local treatment of fungating wounds in combination with a specific treatment. Other Single Use Instruments Curettes Needle Holders Probes Stitch Cutters Skin Staple Removers Proctology More... Bleeding on dressing removal. Forty‐eight percent of the Urgotul ™‐dressed wounds showed no bleeding, 43% versus 13% of Urgotul ™‐dressed and TG‐dressed wounds respectively noted minimal bleeding during first dressing change. Seventeen percent of TG‐dressed wounds had ‘important’ bleeding. None of the Urgotul ™ dressed wounds had ‘important bleeding’.The sacrum version is recommended for exuding wounds located in the sacral area (sacral pressure ulcers….). Pharmaceuticals A - Z Pharmaceuticals - A Pharmaceuticals - B Pharmaceuticals - C Pharmaceuticals - D Pharmaceuticals - E Pharmaceuticals - F Pharmaceuticals - G Pharmaceuticals - H In April 2023, we updated section 1 to reflect the current format of NICE guidance. We also added some text to the clinical evidence section to summarise new clinical evidence reviewed. NICE’s recommendations for UrgoStart remain unchanged. More details are in the review decision. New text is marked [2023]. Implementation Meaume, S., Teot, L., Lazareth, I. et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study. J Wound Care 2004; 13: 10, 409–413. Benbow M., Iosson, G. A clinical evaluation of UrgoTul to treat acute and chronic wounds. Br J Nurs 2004; 13: 2, 105–109.

UrgoTul Absorb Sacrum - Urgo Healthcare Professionals UrgoTul Absorb Sacrum - Urgo Healthcare Professionals

Assessments/Audits Test & Calibration PAT Testing Legionella Risk Assessment Fire Risk Assessment Health & Safety Audit Disability Access Audit UrgoStart is used in patients with leg ulcers, diabetic foot ulcers and pressure ulcers, from whenever granulation tissue appears until complete healing. In the case of deep wounds and fistula wounds, a section of the dressing should be left visible to enable easy removal. In the absence of clinical data relative to uncomplicated acute wounds and in the context of Epidermolysis Bullosa, irrespective of duration, the use of UrgoStart is not recommended. National Institute for Health and Care Excellence (NICE), UrgoStart for treating leg ulcers and diabetic foot ulcers, https://www.nice.org.uk/guidance/mtg42, April 2023UrgoStart should be changed every 2 to 4 days on average, and may be left in place for up to 7 days, depending on the exudate volume and the clinical condition of the wound.